Former Chief Justice of India RC Lahoti passes away at 81; PM Modi, law minister condole demise

-

Former Chief Justice of India Ramesh Chandra Lahoti died at a hospital here on Wednesday evening, family sources said. He was 81 years old. Justice Lahoti was appointed as the 35th chief justice of India on June 1, 2004. He retired on November 1, 2005. He was a former independent director on the board of directors of the Press Trust of India (PTI).

He was appointed as arbitrator by the Government of India in the Rs 20,000 crore high-profile tax dispute case with telecom major Vodafone.

Born on November 1, 1940, he joined the Bar in Guna district in 1960 and enrolled as an advocate in 1962.

He was recruited directly to the bench in April 1977, from the Bar to the State Higher Judicial Service and was appointed as a district and sessions judge.

After serving in the post for a year, Justice Lahoti resigned in May 1978 and returned to the Bar to practice mainly in the High Court.

He was appointed an additional judge of the Madhya Pradesh High Court on May 3, 1988, and made a permanent judge on August 4 the next year.

He was transferred to Delhi High Court on February 7, 1994, and later appointed as a judge of the Supreme Court on December 9, 1998.

Condoling the death of former chief justice, Prime Minister Narendra Modi said on Thursday that he will be remembered for his contributions to the judiciary and emphasis on ensuring speedy justice to the underprivileged.

Union Law Minister Kiren Rijiju condoled the death of Justice Lahoti. "Saddened to hear the passing away of Shri RC Lahoti, former Chief Justice of India. He rose from a humble background and reached the highest position of our country's judiciary because of his ability, knowledge and wisdom," he tweeted.

Madhya Pradesh Chief Minister Shivraj Singh Chouhan, his predecessor Kamal Nath of Congress and other leaders on Wednesday condoled the death of Lahoti. Chouhan termed the ex-CJI’s death an irreparable loss to his family members.

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/5V0jIqr
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more